The efficacy of both drugs was the same in reducing dysmenorrhea, dyspareunia, and dyschezia, and the 2 drugs did not differ in terms of the number of women with hot flashes and joint pain; however, vaginal dryness was more common in GnRH agonists and decreased libido in dienogest users. The gene discussed is GNRH1; the disease is Dysmenorrhea.